136 related articles for article (PubMed ID: 38258451)
1. Drug-induced hypothyroidism in tuberculosis.
Quiroz-Aldave JE; Durand-Vásquez MDC; Gamarra-Osorio ER; Concepción-Urteaga LA; Pecho-Silva S; Rodríguez-Hidalgo LA; Concepción-Zavaleta MJ
Expert Rev Endocrinol Metab; 2024 May; 19(3):199-206. PubMed ID: 38258451
[TBL] [Abstract][Full Text] [Related]
2. Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis.
Tola HH; Holakouie-Naieni K; Lejisa T; Mansournia MA; Yaseri M; Tesfaye E; Mola M
PLoS One; 2019; 14(6):e0218487. PubMed ID: 31211809
[TBL] [Abstract][Full Text] [Related]
3. Hypothyroidism associated with therapy for multi-drug-resistant tuberculosis in Australia.
Cheung YM; Van K; Lan L; Barmanray R; Qian SY; Shi WY; Wong JLA; Hamblin PS; Colman PG; Topliss DJ; Denholm JT; Grossmann M
Intern Med J; 2019 Mar; 49(3):364-372. PubMed ID: 30151969
[TBL] [Abstract][Full Text] [Related]
4. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K
Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388
[TBL] [Abstract][Full Text] [Related]
5. High rate of hypothyroidism among patients treated for multidrug-resistant tuberculosis in Lesotho.
Satti H; Mafukidze A; Jooste PL; McLaughlin MM; Farmer PE; Seung KJ
Int J Tuberc Lung Dis; 2012 Apr; 16(4):468-72. PubMed ID: 22326109
[TBL] [Abstract][Full Text] [Related]
6. Abnormal thyroid function tests in children on ethionamide treatment.
Thee S; Zöllner EW; Willemse M; Hesseling AC; Magdorf K; Schaaf HS
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1191-3, i. PubMed ID: 21943844
[TBL] [Abstract][Full Text] [Related]
7. High rate of hypothyroidism in multidrug-resistant tuberculosis patients co-infected with HIV in Mumbai, India.
Andries A; Isaakidis P; Das M; Khan S; Paryani R; Desai C; Dalal A; Mansoor H; Verma R; Fernandes D; Sotgiu G; Migliori GB; Saranchuk P
PLoS One; 2013; 8(10):e78313. PubMed ID: 24194919
[TBL] [Abstract][Full Text] [Related]
8. A review of the use of ethionamide and prothionamide in childhood tuberculosis.
Thee S; Garcia-Prats AJ; Donald PR; Hesseling AC; Schaaf HS
Tuberculosis (Edinb); 2016 Mar; 97():126-36. PubMed ID: 26586647
[TBL] [Abstract][Full Text] [Related]
9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
10. Hypothyroidism during second-line treatment of multidrug-resistant tuberculosis: a prospective study.
Bares R; Khalid N; Daniel H; Dittmann H; Reimold M; Gallwitz B; Schmotzer C
Int J Tuberc Lung Dis; 2016 Jul; 20(7):876-81. PubMed ID: 27287638
[TBL] [Abstract][Full Text] [Related]
11. Ethionamide-induced hypothyroidism.
Dutta BS; Hassan G; Waseem Q; Saheer S; Singh A
Int J Tuberc Lung Dis; 2012 Jan; 16(1):141. PubMed ID: 22236862
[No Abstract] [Full Text] [Related]
12. Drug-Induced Hypothyroidism during Anti-Tuberculosis Treatment of Multidrug-Resistant Tuberculosis: Notes from the Field.
Munivenkatappa S; Anil S; Naik B; Volkmann T; Sagili KD; Akshatha JS; Buggi S; Sharada MA; Kulkarni S; Chadha VK; Moonan PK
J Tuberc Res; 2016 Sep; 4(3):105-110. PubMed ID: 27595122
[TBL] [Abstract][Full Text] [Related]
13. Anti-tuberculosis drugs adverse reactions: a review of the Iranian literature.
Kargar M; Mansouri A; Hadjibabaie M; Javadi M; Radfar M; Gholami K
Expert Opin Drug Saf; 2014 Jul; 13(7):875-91. PubMed ID: 24935479
[TBL] [Abstract][Full Text] [Related]
14. Hypothyroidism in a patient receiving treatment for multidrug-resistant tuberculosis.
Soumakis SA; Berg D; Harris HW
Clin Infect Dis; 1998 Oct; 27(4):910-1. PubMed ID: 9798062
[No Abstract] [Full Text] [Related]
15. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
Centers for Disease Control and Prevention
MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania.
Mpagama SG; Heysell SK; Ndusilo ND; Kumburu HH; Lekule IA; Kisonga RM; Gratz J; Boeree MJ; Houpt ER; Kibiki GS
PLoS One; 2013; 8(5):e62034. PubMed ID: 23675411
[TBL] [Abstract][Full Text] [Related]
17. Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.
Muñoz-Torrico M; Caminero-Luna J; Migliori GB; D'Ambrosio L; Carrillo-Alduenda JL; Villareal-Velarde H; Torres-Cruz A; Flores-Vergara H; Martínez-Mendoza D; García-Sancho C; Centis R; Salazar-Lezama MÁ; Pérez-Padilla R
Arch Bronconeumol; 2017 May; 53(5):245-250. PubMed ID: 28089216
[TBL] [Abstract][Full Text] [Related]
18. Hypothyroidism due to ethionamide.
McDonnell ME; Braverman LE; Bernardo J
N Engl J Med; 2005 Jun; 352(26):2757-9. PubMed ID: 15987931
[No Abstract] [Full Text] [Related]
19. Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa.
Pietersen E; Anderson K; Cox H; Dheda K; Bian A; Shepherd BE; Sterling TR; Warren RM; van der Heijden YF
PLoS One; 2023; 18(2):e0281097. PubMed ID: 36780443
[TBL] [Abstract][Full Text] [Related]
20. Thyroid Profile and Factors Associated with Hypothyroidism Among Multidrug-Resistant Tuberculosis Patients Attending Saint Peter's Specialized Hospital Addis Ababa, Ethiopia.
Biranu E; Wolde M; Edao Negesso A; Hailu Tola H; Molla Sisay M
Infect Drug Resist; 2021; 14():2675-2684. PubMed ID: 34285520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
